NEW YORK (GenomeWeb News) – Researchers from Harvard University have come up with a method for refining their view of recent signals of natural selection in the human genome.

Pardis Sabeti, an evolutionary biologist at Harvard University's FAS Center for Systems Biology, presented various aspects of the work during two talks at the American Society of Human Genetics meeting in Honolulu last week — one during a session on the medical uses of genomic sequencing and another during the meeting's closing symposium on Darwin and evolutionary biology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.